Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Musculoskeletal | Rheumatology | Nephrology
Disease Category: Systemic Lupus Erythematosus
Location: United States, CA

Clinical Trial Details

Overview

Research Study Summary

A 48 week clinical trial for patients diagnosed with severe to moderate Lupus

Purpose

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study for the Efficacy and Safety of Four 12-Week treatment Cycles (48 weeks total) of Drug in Systemic Lupus Erythematosus Subjects with Moderate to Severe Disease.

Patient Inclusion Criteria:

  • At least 18 years old
  • Diagnosed with Lupus (Moderate to Severe)

Patient Exclusion Criteria:

  • Certain medications- please call to find out if you pre-qualify

To Learn more
Phase

3

Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Duration

48 Weeks

Facility Type

N/A

Contact

California Center for Clinical Research
207 S. Santa Anita St.
San Gabriel, CA 91776
Phone: 626-284-8401

View Map

Research Center Information: California Center for Clinical Research

CW ID: 181011

Date Last Changed: July 19, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.